GAITHERSBURG, Md.--(BUSINESS WIRE)--Ore Pharmaceuticals Inc. (NASDAQ: ORXE) announced today that Chief Executive Officer and President Charles L. Dimmler, III, gave a presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference, that included certain research and development findings, the Company’s current compound development status, and information about its recently published patent application regarding stratification and treatment of the majority of breast cancer patients based on their estrogen receptor alpha status.
